Epigenomics AG (LON:0QXH)
0.9150
-0.1450 (-13.68%)
At close: Aug 24, 2026
| Market Cap | 717.07K +6.2% |
| Revenue (ttm) | 25.83K +172.7% |
| Net Income | -204.94K |
| EPS | -0.23 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5 |
| Open | 0.9150 |
| Previous Close | 1.0600 |
| Day's Range | 0.9150 - 0.9150 |
| 52-Week Range | 0.8820 - 1.0600 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 9, 2026 |